Stock Radar: Divi’s Laboratories stock hits fresh record high in July 2026; time to book profits or buy th
Divi's Laboratories stock reached a new record high in July 2026. Chart patterns indicate continued upward momentum for the pharma stock. Short-term traders can consider buying the stock for a target of 8,000 levels. The stock has shown significant gains over recent weeks and months. Experts recommend buying with a stop loss below 6950 levels.
Divi's Laboratories stock reached a new record high in July 2026. Chart patterns indicate continued upward momentum for the pharma stock. Short-term traders can consider buying the stock for a target of 8,000 levels. The stock has shown significant gains over recent weeks and months. Experts recommend buying with a stop loss below 6950 levels.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
